BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 9741457)

  • 1. Adult and neonatal anti-Gal response in knock-out mice for alpha1,3galactosyltransferase.
    LaTemple DC; Galili U
    Xenotransplantation; 1998 Aug; 5(3):191-6. PubMed ID: 9741457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
    Galili U
    Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of immune tolerance to a transplantation carbohydrate antigen by gene therapy with autologous lymphocytes transduced with adenovirus containing the corresponding glycosyltransferase gene.
    Ogawa H; Yin DP; Galili U
    Gene Ther; 2004 Feb; 11(3):292-301. PubMed ID: 14737089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. α1,3Galactosyltransferase knockout pigs produce the natural anti-Gal antibody and simulate the evolutionary appearance of this antibody in primates.
    Galili U
    Xenotransplantation; 2013; 20(5):267-76. PubMed ID: 23968556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased immunogenicity of tumor vaccines complexed with anti-Gal: studies in knockout mice for alpha1,3galactosyltransferase.
    LaTemple DC; Abrams JT; Zhang SY; Galili U
    Cancer Res; 1999 Jul; 59(14):3417-23. PubMed ID: 10416604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerance induction to a mammalian blood group-like carbohydrate antigen by syngeneic lymphocytes expressing the antigen, II: tolerance induction on memory B cells.
    Mohiuddin MM; Ogawa H; Yin DP; Galili U
    Blood; 2003 Jul; 102(1):229-36. PubMed ID: 12649147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo targeting of vaccinating tumor cells to antigen-presenting cells by a gene therapy method with adenovirus containing the alpha1,3galactosyltransferase gene.
    Deriy L; Ogawa H; Gao GP; Galili U
    Cancer Gene Ther; 2005 Jun; 12(6):528-39. PubMed ID: 15818383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The alpha-gal epitope and the anti-Gal antibody in xenotransplantation and in cancer immunotherapy.
    Galili U
    Immunol Cell Biol; 2005 Dec; 83(6):674-86. PubMed ID: 16266320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse-heart grafts expressing an incompatible carbohydrate antigen. II. Transition from accommodation to tolerance.
    Ogawa H; Mohiuddin MM; Yin DP; Shen J; Chong AS; Galili U
    Transplantation; 2004 Feb; 77(3):366-73. PubMed ID: 14966409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. alpha-galactosyl (Galalpha1-3Galbeta1-4GlcNAc-R) epitopes on human cells: synthesis of the epitope on human red cells by recombinant primate alpha1,3galactosyltransferase expressed in E.coli.
    Galili U; Anaraki F
    Glycobiology; 1995 Dec; 5(8):775-82. PubMed ID: 8720075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of α-Gal epitope, anti-Gal antibody, α1,3 galactosyltransferase and its clinical exploitation (Review).
    Huai G; Qi P; Yang H; Wang Y
    Int J Mol Med; 2016 Jan; 37(1):11-20. PubMed ID: 26531137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-mediated accommodation of heart grafts expressing an incompatible carbohydrate antigen.
    Mohiuddin MM; Ogawa H; Yin DP; Shen J; Galili U
    Transplantation; 2003 Feb; 75(3):258-62. PubMed ID: 12589143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elimination of anti-Gal B cells by alpha-Gal ricin1.
    Tanemura M; Ogawa H; Yin DP; Chen ZC; DiSesa VJ; Galili U
    Transplantation; 2002 Jun; 73(12):1859-68. PubMed ID: 12131678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fetal porcine thymus engraftment, survival and CD4 reconstitution in alphaGal-KO mice is impaired in the presence of high levels of antibodies against alphaGal.
    Rodriguez-Barbosa JI; Zhao Y; Houser S; Zhao G; Sykes M
    Xenotransplantation; 2003 Jan; 10(1):24-40. PubMed ID: 12535223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous tumor vaccines processed to express alpha-gal epitopes: a practical approach to immunotherapy in cancer.
    Galili U
    Cancer Immunol Immunother; 2004 Nov; 53(11):935-45. PubMed ID: 15205919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of cyclophosphamide-induced tolerance in alpha1,3-galactosyltransferase knockout mice presensitized with Gal alpha 1-3Gal beta-4-GlcNAc antigens.
    Onzuka T; Shimizu I; Tomita Y; Iwai T; Okano S; Tominaga R
    Surg Today; 2008; 38(9):807-14. PubMed ID: 18751946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial ovarian cancer stem-like cells expressing α-gal epitopes increase the immunogenicity of tumor associated antigens.
    Yao X; Dong Z; Zhang Q; Wang Q; Lai D
    BMC Cancer; 2015 Dec; 15():956. PubMed ID: 26673159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerance induction to a mammalian blood group-like carbohydrate antigen by syngeneic lymphocytes expressing the antigen.
    Ogawa H; Yin DP; Shen J; Galili U
    Blood; 2003 Mar; 101(6):2318-20. PubMed ID: 12406874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of alpha-gal epitopes (Galalpha1-3Galbeta1-4GlcNAc-R) on human tumor cells by recombinant alpha1,3galactosyltransferase produced in Pichia pastoris.
    Chen ZC; Tanemura M; Galili U
    Glycobiology; 2001 Jul; 11(7):577-86. PubMed ID: 11447137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of alpha-gal epitopes on HeLa cells transduced with adenovirus containing alpha1,3galactosyltransferase cDNA.
    Deriy L; Chen ZC; Gao GP; Galili U
    Glycobiology; 2002 Feb; 12(2):135-44. PubMed ID: 11886847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.